Industry Research Reports
Home > Reports > Service & Software > Global Pre-Pregnancy Genetic Screening Service Market Outlook, In‑Depth Analysis & Forecast to 2031
Global Pre-Pregnancy Genetic Screening Service Market Outlook, In‑Depth Analysis & Forecast to 2031
Industry: Service & Software
Published Date: 2025-08-21
Pages: 146 Pages
Report ld: 4926997
Request Sample
Customized Report
- Description
- Table of Contents
- Table of Figures
- Related Reports
PDF Download
- Description
- Table of Contents
- Table of Figures
- Related Reports
- PDF Download
Pre-Pregnancy Genetic Screening Service Market Size(US$)
CAGR 2025-2031
9.2%
Market Size,2031
USD 349
Million
Market Snapshot
Market Size in 2025 (Value)
US$ 206 million
Market Forecast in 2031(Value)
US$ 349 million
CAGR
9.2%
Years Considered
2020-2031
Base Year
2025
Forecast Period
2025-2031
Source: Secondary research, interviews with experts, and QYResearch analysis
The global Pre-Pregnancy Genetic Screening Service market is projected to grow from US$ 189 million in 2024 to US$ 349 million by 2031, at a CAGR of 9.2% (2025-2031), driven by critical product segments and diverse end‑use applications.
Pre-pregnancy genetic screening service is a medical testing service for couples planning pregnancy. By collecting blood or oral swab samples, the genetic genes carried are analyzed to identify the risk of genetic mutations that may affect the health of the embryo or cause genetic diseases. This provides a scientific basis for fertility decision-making, pregnancy management and fertility risk prevention, helping families reduce the incidence of genetic diseases and achieve safe and healthy fertility planning.
From a downstream perspective, Medical and Health Institutions accounted for % of 2024 revenue, surging to US$ million by 2031 (CAGR: % from 2025–2031).
Pre-Pregnancy Genetic Screening Service leading manufacturers including Invitae, Natera, Fulgent Genetics, Myriad Genetics, Quest Diagnostics, LabCorp, GeneDx, Vitrolife, Illumina, BillionToOne, etc., dominate supply; the top five capture approximately % of global revenue, with Invitae leading 2024 sales at US$ million.
Regional Outlook:
North America rose from US$ million in 2024 to a forecast US$ million by 2031 (CAGR %).
Asia‑Pacific will expand from US$ million to US$ million (CAGR %), led by China (US$ million in 2024, % share rising to % by 2031), Japan (CAGR %), South Korea (CAGR %), and Southeast Asia (CAGR %).
Europe is set to grow from US$ million to US$ million (CAGR %), with Germany projected to hit US$ million by 2031 (CAGR %).
Report Includes:
This definitive report equips CEOs, marketing directors, and investors with a 360° view of the global Pre-Pregnancy Genetic Screening Service market across value chain. It analyzes historical revenue data (2020–2024) and delivers forecasts through 2031, illuminating demand trends and growth drivers.
By segmenting the market by Type and by Application, the study quantifies market size, growth rates, niche opportunities, and substitution risks, and analyzes downstream customers distribution pattern.
Granular regional insights cover five major markets—North America, Europe, APAC, South America, and MEA—with in‑depth analysis of 20+ countries, detailing dominant products, competitive landscape, and downstream demand trends.
Critical competitive intelligence profiles players—revenue, margins, pricing strategies, and major customers—and dissects the top-player positioning across product lines, applications, and regions to reveal strategic strengths.
A concise Industry‑chain overview maps upstream, middlestream, and downstream distribution dynamics to identify strategic gaps and unmet demand.
MARKET SEGMENTATION
By Company
- Invitae
- Natera
- Fulgent Genetics
- Myriad Genetics
- Quest Diagnostics
- LabCorp
- GeneDx
- Vitrolife
- Illumina
- BillionToOne
- Juno Genetics
- MedGenome
- 23andMe
- Sonic Genetics
- CEN4GEN
- BGI Genomics
- Berry Genomics
- Anoroad
- KingMed Diagnostics
- CapitalBio Technology
Consumption by Region
- North America
- United States
- Canada
- Asia-Pacific
- China
- Japan
- South Korea
- Southeast Asia
- India
- Australia
- Rest of Asia-Pacific
- Europe
- Germany
- France
- U.K.
- Italy
- Netherlands
- Nordic Countries
- Rest of Europe
- Latin America
- Mexico
- Brazil
- Rest of Latin America
- Middle East & Africa
- Turkey
- Saudi Arabia
- UAE
- Rest of MEA
Segment by Type
- Single Disease Screening
- Whole Genome Screening
Segment by Application
- Medical and Health Institutions
- Research and Educational Institutions
- Others
Segment by Category
- Laboratory Testing Type
- Comprehensive Consulting Type
- Others
CHAPTER OUTLINE
Chapter 1: Defines the Pre-Pregnancy Genetic Screening Service study scope, segments the market by Type and by Application, etc, highlights segment size and growth potential.
Chapter 2: Offers current market state, projects global revenue and sales to 2031, pinpointing high consumption regions and emerging market catalysts
Chapter 3: Dissects the player landscape—ranks by revenue and profitability, details Player performance by product type and evaluates concentration alongside M&A moves.
Chapter 4: Unlocks high margin product segments—compares revenue, ASP, and technology differentiators, highlighting growth niches and substitution risks
Chapter 5: Targets downstream market opportunities—evaluates market size by Application, identifies emerging use cases, and profiles leading customers by region and by Application.
Chapter 6: North America—breaks down market size by Type, by Application and country, profiles key players and assesses growth drivers and barriers.
Chapter 7: Europe—analyses regional market by Type, by Application and players, flagging drivers and barriers.
Chapter 8: Asia Pacific—quantifies market size by Type, by Application, and region/country, profiles top players, and uncovers high potential expansion areas.
Chapter 9: Central & South America—measures market size by Type, by Application, and country, profiles top players, and identifies investment opportunities and challenges.
Chapter 10: Middle East and Africa—evaluates market size by Type, by Application, and country, profiles key players, and outlines investment prospects and market hurdles
Chapter 11: Profiles players in depth—details product specs, revenue, margins; Top-tier players 2024 sales breakdowns by Product type, by Application, by region SWOT analysis, and recent strategic developments.
Chapter 12: Industry chain—analyses upstream, cost drivers, plus downstream channels.
Chapter 13: Market dynamics—explores drivers, restraints, regulatory impacts, and risk mitigation strategies.
Chapter 14: Actionable conclusions and strategic recommendations.
WHY THIS REPORT
Beyond standard market data, this analysis provides a clear profitability roadmap, empowering you to:
Beyond standard market data, this analysis provides a clear profitability roadmap—empowering you to:
Allocate capital strategically to high growth regions (Chapters 6–10) and margin rich segments (Chapter 5).
Negotiate from strength with suppliers (Chapter 12) and customers (Chapter 5) using cost and demand intelligence.
Outmaneuver competitors with granular insights into their operations, margins, and strategies (Chapters 3 and 11).
Capitalize on the projected billion‑dollar opportunity with data‑driven regional and segment tactics (Chapter 12-14).
Leverage this 360° intelligence to turn market complexity into actionable competitive advantage.
QYRESEARCH'S STRENGTHS
Unlike generic global market reports, this study combines macro-level industry trends with hyper-local operational intelligence, empowering data-driven decisions across the Compound Chocolate value chain, addressing:
Market entry risks/opportunities by region
We identify regional market threats and growth prospects to guide your overseas layout.
Product mix optimization based on local practices
We adjust product portfolios in line with local consumption habits.
Competitor tactics in fragmented vs. consolidated markets
We unpack rivals’ operation strategies for scattered and highly concentrated industries.
Full Research Coverage
We cover competition landscape, full supply chain and quantified market size data, and deliver tailor-made customized surveys to meet your unique business demands.
19 Years Industry Expertise
We own self-owned massive exclusive databases, backed by 19 years of global market research experience across thousands of sectors.
24/7 Fast Report Delivery
Our team operates 24 hours a day, 365 days a year, enabling ultra-fast report turnaround to respond to your research needs efficiently.
Localized Strategic Analysis
We integrate regional risk assessment, localized product optimization and competitor analysis to deliver actionable market strategies.
Market entry risks/opportunities by region
All data is cross-verified from multiple industry sources to deliver thorough, precise analysis that supports reliable corporate strategic decisions.
Market entry risks/opportunities by region
We provide responsive, dedicated after-sales support to resolve all follow-up inquiries about reports, data and industry interpretation.
TABLE OF CONTENTS
1 Study Coverage
1.1 Introduction to Pre-Pregnancy Genetic Screening Service: Definition, Properties, and Key Attributes
1.2 Market Segmentation by Type
1.2.1 Global Pre-Pregnancy Genetic Screening Service Market Size by Type, 2020 VS 2024 VS 2031
1.2.2 Single Disease Screening
1.2.3 Whole Genome Screening
1.3 Market Segmentation by Application
1.3.1 Global Pre-Pregnancy Genetic Screening Service Market Size by Application, 2020 VS 2024 VS 2031
1.3.2 Medical and Health Institutions
1.3.3 Research and Educational Institutions
1.3.4 Others
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Executive Summary
2.1 Global Pre-Pregnancy Genetic Screening Service Revenue Estimates and Forecasts 2020-2031
2.2 Global Pre-Pregnancy Genetic Screening Service Revenue by Region
2.2.1 Revenue Comparison: 2020 VS 2024 VS 2031
2.2.2 Historical and Forecasted Revenue by Region (2020-2031)
2.2.3 Global Revenue Market Share by Region (2020-2031)
2.2.4 Emerging Market Focus: Growth Drivers & Investment Trends
3 Competition by Players
3.1 Global Pre-Pregnancy Genetic Screening Service Player Revenue Rankings and Profitability
3.1.1 Global Revenue (Value) by Players (2020-2025)
3.1.2 Global Key Player Revenue Ranking (2023 vs. 2024)
3.1.3 Revenue-Based Tier Segmentation (Tier 1, Tier 2, and Tier 3)
3.1.4 Gross Margin by Top Player (2020 VS 2024)
3.2 Global Pre-Pregnancy Genetic Screening Service Companies Headquarters and Service Footprint
3.3 Main Product Type Market Size by Players
3.3.1 Single Disease Screening Market Size by Players
3.3.2 Whole Genome Screening Market Size by Players
3.4 Global Pre-Pregnancy Genetic Screening Service Market Concentration and Dynamics
3.4.1 Global Market Concentration (CR5 and HHI)
3.4.2 Entrant/Exit Impact Analysis
3.4.3 Strategic Moves: M&A, Expansion, R&D Investment
4 Global Product Segmentation Analysis
4.1 Global Pre-Pregnancy Genetic Screening Service Revenue Trends by Type
4.1.1 Global Historical and Forecasted Revenue by Type (2020-2031)
4.1.2 Global Revenue Market Share by Type (2020-2031)
4.2 Key Product Attributes and Differentiation
4.3 Subtype Dynamics: Growth Leaders, Profitability and Risk
4.3.1 High-Growth Niches and Adoption Drivers
4.3.2 Profitability Hotspots and Cost Drivers
4.3.3 Substitution Threats
5 Global Downstream Application Analysis
5.1 Global Pre-Pregnancy Genetic Screening Service Revenue by Application
5.1.1 Global Historical and Forecasted Revenue by Application (2020-2031)
5.1.2 Revenue Market Share by Application (2020-2031)
5.1.3 High-Growth Application Identification
5.1.4 Emerging Application Case Studies
5.2 Downstream Customer Analysis
5.2.1 Top Customers by Region
5.2.2 Top Customers by Application
6 North America
6.1 North America Market Size (2020-2031)
6.2 North America Key Players Revenue in 2024
6.3 North America Pre-Pregnancy Genetic Screening Service Market Size by Type (2020-2031)
6.4 North America Pre-Pregnancy Genetic Screening Service Market Size by Application (2020-2031)
6.5 North America Growth Accelerators and Market Barriers
6.6 North America Pre-Pregnancy Genetic Screening Service Market Size by Country
6.6.1 North America Revenue Trends by Country
6.6.2 US
6.6.3 Canada
6.6.4 Mexico
7 Europe
7.1 Europe Market Size (2020-2031)
7.2 Europe Key Players Revenue in 2024
7.3 Europe Pre-Pregnancy Genetic Screening Service Market Size by Type (2020-2031)
7.4 Europe Pre-Pregnancy Genetic Screening Service Market Size by Application (2020-2031)
7.5 Europe Growth Accelerators and Market Barriers
7.6 Europe Pre-Pregnancy Genetic Screening Service Market Size by Country
7.6.1 Europe Revenue Trends by Country
7.6.2 Germany
7.6.3 France
7.6.4 U.K.
7.6.5 Italy
7.6.6 Russia
8 Asia-Pacific
8.1 Asia-Pacific Market Size (2020-2031)
8.2 Asia-Pacific Key Players Revenue in 2024
8.3 Asia-Pacific Pre-Pregnancy Genetic Screening Service Market Size by Type (2020-2031)
8.4 Asia-Pacific Pre-Pregnancy Genetic Screening Service Market Size by Application (2020-2031)
8.5 Asia-Pacific Growth Accelerators and Market Barriers
8.6 Asia-Pacific Pre-Pregnancy Genetic Screening Service Market Size by Region
8.6.1 Asia-Pacific Revenue Trends by Region
8.7 China
8.8 Japan
8.9 South Korea
8.10 Australia
8.11 India
8.12 Southeast Asia
8.12.1 Indonesia
8.12.2 Vietnam
8.12.3 Malaysia
8.12.4 Philippines
8.12.5 Singapore
9 Central and South America
9.1 Central and South America Market Size (2020-2031)
9.2 Central and South America Key Players Revenue in 2024
9.3 Central and South America Pre-Pregnancy Genetic Screening Service Market Size by Type (2020-2031)
9.4 Central and South America Pre-Pregnancy Genetic Screening Service Market Size by Application (2020-2031)
9.5 Central and South America Investment Opportunities and Key Challenges
9.6 Central and South America Pre-Pregnancy Genetic Screening Service Market Size by Country
9.6.1 Central and South America Revenue Trends by Country (2020 VS 2024 VS 2031)
9.6.2 Brazil
9.6.3 Argentina
10 Middle East and Africa
10.1 Middle East and Africa Market Size (2020-2031)
10.2 Middle East and Africa Key Players Revenue in 2024
10.3 Middle East and Africa Pre-Pregnancy Genetic Screening Service Market Size by Type (2020-2031)
10.4 Middle East and Africa Pre-Pregnancy Genetic Screening Service Market Size by Application (2020-2031)
10.5 Middle East and Africa Investment Opportunities and Key Challenges
10.6 Middle East and Africa Pre-Pregnancy Genetic Screening Service Market Size by Country
10.6.1 Middle East and Africa Revenue Trends by Country (2020 VS 2024 VS 2031)
10.6.2 GCC Countries
10.6.3 Israel
10.6.4 Egypt
10.6.5 South Africa
11 Corporate Profile
11.1 Invitae
11.1.1 Invitae Corporation Information
11.1.2 Invitae Business Overview
11.1.3 Invitae Pre-Pregnancy Genetic Screening Service Product Features and Attributes
11.1.4 Invitae Pre-Pregnancy Genetic Screening Service Revenue and Gross Margin (2020-2025)
11.1.5 Invitae Pre-Pregnancy Genetic Screening Service Revenue by Product in 2024
11.1.6 Invitae Pre-Pregnancy Genetic Screening Service Revenue by Application in 2024
11.1.7 Invitae Pre-Pregnancy Genetic Screening Service Revenue by Geographic Area in 2024
11.1.8 Invitae Pre-Pregnancy Genetic Screening Service SWOT Analysis
11.1.9 Invitae Recent Developments
11.2 Natera
11.2.1 Natera Corporation Information
11.2.2 Natera Business Overview
11.2.3 Natera Pre-Pregnancy Genetic Screening Service Product Features and Attributes
11.2.4 Natera Pre-Pregnancy Genetic Screening Service Revenue and Gross Margin (2020-2025)
11.2.5 Natera Pre-Pregnancy Genetic Screening Service Revenue by Product in 2024
11.2.6 Natera Pre-Pregnancy Genetic Screening Service Revenue by Application in 2024
11.2.7 Natera Pre-Pregnancy Genetic Screening Service Revenue by Geographic Area in 2024
11.2.8 Natera Pre-Pregnancy Genetic Screening Service SWOT Analysis
11.2.9 Natera Recent Developments
11.3 Fulgent Genetics
11.3.1 Fulgent Genetics Corporation Information
11.3.2 Fulgent Genetics Business Overview
11.3.3 Fulgent Genetics Pre-Pregnancy Genetic Screening Service Product Features and Attributes
11.3.4 Fulgent Genetics Pre-Pregnancy Genetic Screening Service Revenue and Gross Margin (2020-2025)
11.3.5 Fulgent Genetics Pre-Pregnancy Genetic Screening Service Revenue by Product in 2024
11.3.6 Fulgent Genetics Pre-Pregnancy Genetic Screening Service Revenue by Application in 2024
11.3.7 Fulgent Genetics Pre-Pregnancy Genetic Screening Service Revenue by Geographic Area in 2024
11.3.8 Fulgent Genetics Pre-Pregnancy Genetic Screening Service SWOT Analysis
11.3.9 Fulgent Genetics Recent Developments
11.4 Myriad Genetics
11.4.1 Myriad Genetics Corporation Information
11.4.2 Myriad Genetics Business Overview
11.4.3 Myriad Genetics Pre-Pregnancy Genetic Screening Service Product Features and Attributes
11.4.4 Myriad Genetics Pre-Pregnancy Genetic Screening Service Revenue and Gross Margin (2020-2025)
11.4.5 Myriad Genetics Pre-Pregnancy Genetic Screening Service Revenue by Product in 2024
11.4.6 Myriad Genetics Pre-Pregnancy Genetic Screening Service Revenue by Application in 2024
11.4.7 Myriad Genetics Pre-Pregnancy Genetic Screening Service Revenue by Geographic Area in 2024
11.4.8 Myriad Genetics Pre-Pregnancy Genetic Screening Service SWOT Analysis
11.4.9 Myriad Genetics Recent Developments
11.5 Quest Diagnostics
11.5.1 Quest Diagnostics Corporation Information
11.5.2 Quest Diagnostics Business Overview
11.5.3 Quest Diagnostics Pre-Pregnancy Genetic Screening Service Product Features and Attributes
11.5.4 Quest Diagnostics Pre-Pregnancy Genetic Screening Service Revenue and Gross Margin (2020-2025)
11.5.5 Quest Diagnostics Pre-Pregnancy Genetic Screening Service Revenue by Product in 2024
11.5.6 Quest Diagnostics Pre-Pregnancy Genetic Screening Service Revenue by Application in 2024
11.5.7 Quest Diagnostics Pre-Pregnancy Genetic Screening Service Revenue by Geographic Area in 2024
11.5.8 Quest Diagnostics Pre-Pregnancy Genetic Screening Service SWOT Analysis
11.5.9 Quest Diagnostics Recent Developments
11.6 LabCorp
11.6.1 LabCorp Corporation Information
11.6.2 LabCorp Business Overview
11.6.3 LabCorp Pre-Pregnancy Genetic Screening Service Product Features and Attributes
11.6.4 LabCorp Pre-Pregnancy Genetic Screening Service Revenue and Gross Margin (2020-2025)
11.6.5 LabCorp Recent Developments
11.7 GeneDx
11.7.1 GeneDx Corporation Information
11.7.2 GeneDx Business Overview
11.7.3 GeneDx Pre-Pregnancy Genetic Screening Service Product Features and Attributes
11.7.4 GeneDx Pre-Pregnancy Genetic Screening Service Revenue and Gross Margin (2020-2025)
11.7.5 GeneDx Recent Developments
11.8 Vitrolife
11.8.1 Vitrolife Corporation Information
11.8.2 Vitrolife Business Overview
11.8.3 Vitrolife Pre-Pregnancy Genetic Screening Service Product Features and Attributes
11.8.4 Vitrolife Pre-Pregnancy Genetic Screening Service Revenue and Gross Margin (2020-2025)
11.8.5 Vitrolife Recent Developments
11.9 Illumina
11.9.1 Illumina Corporation Information
11.9.2 Illumina Business Overview
11.9.3 Illumina Pre-Pregnancy Genetic Screening Service Product Features and Attributes
11.9.4 Illumina Pre-Pregnancy Genetic Screening Service Revenue and Gross Margin (2020-2025)
11.9.5 Illumina Recent Developments
11.10 BillionToOne
11.10.1 BillionToOne Corporation Information
11.10.2 BillionToOne Business Overview
11.10.3 BillionToOne Pre-Pregnancy Genetic Screening Service Product Features and Attributes
11.10.4 BillionToOne Pre-Pregnancy Genetic Screening Service Revenue and Gross Margin (2020-2025)
11.10.5 Company Ten Recent Developments
11.11 Juno Genetics
11.11.1 Juno Genetics Corporation Information
11.11.2 Juno Genetics Business Overview
11.11.3 Juno Genetics Pre-Pregnancy Genetic Screening Service Product Features and Attributes
11.11.4 Juno Genetics Pre-Pregnancy Genetic Screening Service Revenue and Gross Margin (2020-2025)
11.11.5 Juno Genetics Recent Developments
11.12 MedGenome
11.12.1 MedGenome Corporation Information
11.12.2 MedGenome Business Overview
11.12.3 MedGenome Pre-Pregnancy Genetic Screening Service Product Features and Attributes
11.12.4 MedGenome Pre-Pregnancy Genetic Screening Service Revenue and Gross Margin (2020-2025)
11.12.5 MedGenome Recent Developments
11.13 23andMe
11.13.1 23andMe Corporation Information
11.13.2 23andMe Business Overview
11.13.3 23andMe Pre-Pregnancy Genetic Screening Service Product Features and Attributes
11.13.4 23andMe Pre-Pregnancy Genetic Screening Service Revenue and Gross Margin (2020-2025)
11.13.5 23andMe Recent Developments
11.14 Sonic Genetics
11.14.1 Sonic Genetics Corporation Information
11.14.2 Sonic Genetics Business Overview
11.14.3 Sonic Genetics Pre-Pregnancy Genetic Screening Service Product Features and Attributes
11.14.4 Sonic Genetics Pre-Pregnancy Genetic Screening Service Revenue and Gross Margin (2020-2025)
11.14.5 Sonic Genetics Recent Developments
11.15 CEN4GEN
11.15.1 CEN4GEN Corporation Information
11.15.2 CEN4GEN Business Overview
11.15.3 CEN4GEN Pre-Pregnancy Genetic Screening Service Product Features and Attributes
11.15.4 CEN4GEN Pre-Pregnancy Genetic Screening Service Revenue and Gross Margin (2020-2025)
11.15.5 CEN4GEN Recent Developments
11.16 BGI Genomics
11.16.1 BGI Genomics Corporation Information
11.16.2 BGI Genomics Business Overview
11.16.3 BGI Genomics Pre-Pregnancy Genetic Screening Service Product Features and Attributes
11.16.4 BGI Genomics Pre-Pregnancy Genetic Screening Service Revenue and Gross Margin (2020-2025)
11.16.5 BGI Genomics Recent Developments
11.17 Berry Genomics
11.17.1 Berry Genomics Corporation Information
11.17.2 Berry Genomics Business Overview
11.17.3 Berry Genomics Pre-Pregnancy Genetic Screening Service Product Features and Attributes
11.17.4 Berry Genomics Pre-Pregnancy Genetic Screening Service Revenue and Gross Margin (2020-2025)
11.17.5 Berry Genomics Recent Developments
11.18 Anoroad
11.18.1 Anoroad Corporation Information
11.18.2 Anoroad Business Overview
11.18.3 Anoroad Pre-Pregnancy Genetic Screening Service Product Features and Attributes
11.18.4 Anoroad Pre-Pregnancy Genetic Screening Service Revenue and Gross Margin (2020-2025)
11.18.5 Anoroad Recent Developments
11.19 KingMed Diagnostics
11.19.1 KingMed Diagnostics Corporation Information
11.19.2 KingMed Diagnostics Business Overview
11.19.3 KingMed Diagnostics Pre-Pregnancy Genetic Screening Service Product Features and Attributes
11.19.4 KingMed Diagnostics Pre-Pregnancy Genetic Screening Service Revenue and Gross Margin (2020-2025)
11.19.5 KingMed Diagnostics Recent Developments
11.20 CapitalBio Technology
11.20.1 CapitalBio Technology Corporation Information
11.20.2 CapitalBio Technology Business Overview
11.20.3 CapitalBio Technology Pre-Pregnancy Genetic Screening Service Product Features and Attributes
11.20.4 CapitalBio Technology Pre-Pregnancy Genetic Screening Service Revenue and Gross Margin (2020-2025)
11.20.5 CapitalBio Technology Recent Developments
12 Pre-Pregnancy Genetic Screening ServiceIndustry Chain Analysis
12.1 Pre-Pregnancy Genetic Screening Service Industry Chain
12.2 Upstream Analysis
12.2.1 Upstream Key Suppliers
12.3 Middlestream Analysis
12.4 Downstream Sales Model and Distribution Networks
12.4.1 Sales Channels
12.4.2 Distributors
13 Pre-Pregnancy Genetic Screening Service Market Dynamics
13.1 Industry Trends and Evolution
13.2 Market Growth Drivers and Emerging Opportunities
13.3 Market Challenges, Risks, and Restraints
14 Key Findings in the Global Pre-Pregnancy Genetic Screening Service Study
15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.1.1 Research Programs/Design
15.1.1.2 Market Size Estimation
15.1.1.3 Market Breakdown and Data Triangulation
15.1.2 Data Source
15.1.2.1 Secondary Sources
15.1.2.2 Primary Sources
15.2 Author Details
TABLE OF FIGURES
List of Tables
Table 1. Global Pre-Pregnancy Genetic Screening Service Market Size Growth Rate by Type, 2020 VS 2024 VS 2031 (US$ Million)
Table 2. Global Pre-Pregnancy Genetic Screening Service Market Size Growth Rate by Application, 2020 VS 2024 VS 2031 (US$ Million)
Table 3. Global Pre-Pregnancy Genetic Screening Service Revenue Grow Rate (CAGR) by Region: 2020 VS 2024 VS 2031 (US$ Million)
Table 4. Global Pre-Pregnancy Genetic Screening Service Revenue by Region (2020-2025) & (US$ Million)
Table 5. Global Pre-Pregnancy Genetic Screening Service Revenue by Region (2026-2031) & (US$ Million)
Table 6. Emerging Market Revenue Grow Rate (CAGR) by Country (2020 VS 2024 VS 2031) (US$ Million)
Table 7. Global Pre-Pregnancy Genetic Screening Service Revenue by Players (2020-2025) & (US$ Million)
Table 8. Global Pre-Pregnancy Genetic Screening Service Revenue Market Share by Players (2020-2025)
Table 9. Global Key Players’Ranking Shift (2023 vs. 2024) (Based on Revenue)
Table 10. Global Pre-Pregnancy Genetic Screening Service by Player Tier (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Pre-Pregnancy Genetic Screening Service as of 2024)
Table 11. Global Pre-Pregnancy Genetic Screening Service Average Gross Margin (%) by Player (2020 VS 2024)
Table 12. Global Pre-Pregnancy Genetic Screening Service Companies Headquarters
Table 13. Global Pre-Pregnancy Genetic Screening Service Market Concentration Ratio (CR5 and HHI)
Table 14. Key Market Entrant/Exit (2020-2024) – Drivers & Impact Analysis
Table 15. Key Mergers & Acquisitions, Expansion Plans, R&D Investment
Table 16. Global Pre-Pregnancy Genetic Screening Service Revenue by Type (2020-2025) & (US$ Million)
Table 17. Global Pre-Pregnancy Genetic Screening Service Revenue by Type (2026-2031) & (US$ Million)
Table 18. Key Product Attributes and Differentiation
Table 19. Global Pre-Pregnancy Genetic Screening Service Revenue by Application (2020-2025) & (US$ Million)
Table 20. Global Pre-Pregnancy Genetic Screening Service Revenue by Application (2026-2031) & (US$ Million)
Table 21. Pre-Pregnancy Genetic Screening Service High-Growth Sectors Demand CAGR (2024-2031)
Table 22. Top Customers by Region
Table 23. Top Customers by Application
Table 24. North America Pre-Pregnancy Genetic Screening Service Growth Accelerators and Market Barriers
Table 25. North America Pre-Pregnancy Genetic Screening Service Revenue Grow Rate (CAGR) by Country (2020 VS 2024 VS 2031) (US$ Million)
Table 26. Europe Pre-Pregnancy Genetic Screening Service Growth Accelerators and Market Barriers
Table 27. Europe Pre-Pregnancy Genetic Screening Service Revenue Grow Rate (CAGR) by Country: 2020 VS 2024 VS 2031 (US$ Million)
Table 28. Asia-Pacific Pre-Pregnancy Genetic Screening Service Growth Accelerators and Market Barriers
Table 29. Asia-Pacific Pre-Pregnancy Genetic Screening Service Revenue Grow Rate (CAGR) by Region: 2020 VS 2024 VS 2031 (US$ Million)
Table 30. Central and South America Pre-Pregnancy Genetic Screening Service Investment Opportunities and Key Challenges
Table 31. Central and South America Pre-Pregnancy Genetic Screening Service Revenue Grow Rate (CAGR) by Country (2020 VS 2024 VS 2031) (US$ Million)
Table 32. Middle East and Africa Pre-Pregnancy Genetic Screening Service Investment Opportunities and Key Challenges
Table 33. Middle East and Africa Pre-Pregnancy Genetic Screening Service Revenue Grow Rate (CAGR) by Country (2020 VS 2024 VS 2031) (US$ Million)
Table 34. Invitae Corporation Information
Table 35. Invitae Description and Major Businesses
Table 36. Invitae Product Features and Attributes
Table 37. Invitae Revenue (US$ Million) and Gross Margin (2020-2025)
Table 38. Invitae Revenue Proportion by Product in 2024
Table 39. Invitae Revenue Proportion by Application in 2024
Table 40. Invitae Revenue Proportion by Geographic Area in 2024
Table 41. Invitae Pre-Pregnancy Genetic Screening Service SWOT Analysis
Table 42. Invitae Recent Developments
Table 43. Natera Corporation Information
Table 44. Natera Description and Major Businesses
Table 45. Natera Product Features and Attributes
Table 46. Natera Revenue (US$ Million) and Gross Margin (2020-2025)
Table 47. Natera Revenue Proportion by Product in 2024
Table 48. Natera Revenue Proportion by Application in 2024
Table 49. Natera Revenue Proportion by Geographic Area in 2024
Table 50. Natera Pre-Pregnancy Genetic Screening Service SWOT Analysis
Table 51. Natera Recent Developments
Table 52. Fulgent Genetics Corporation Information
Table 53. Fulgent Genetics Description and Major Businesses
Table 54. Fulgent Genetics Product Features and Attributes
Table 55. Fulgent Genetics Revenue (US$ Million) and Gross Margin (2020-2025)
Table 56. Fulgent Genetics Revenue Proportion by Product in 2024
Table 57. Fulgent Genetics Revenue Proportion by Application in 2024
Table 58. Fulgent Genetics Revenue Proportion by Geographic Area in 2024
Table 59. Fulgent Genetics Pre-Pregnancy Genetic Screening Service SWOT Analysis
Table 60. Fulgent Genetics Recent Developments
Table 61. Myriad Genetics Corporation Information
Table 62. Myriad Genetics Description and Major Businesses
Table 63. Myriad Genetics Product Features and Attributes
Table 64. Myriad Genetics Revenue (US$ Million) and Gross Margin (2020-2025)
Table 65. Myriad Genetics Revenue Proportion by Product in 2024
Table 66. Myriad Genetics Revenue Proportion by Application in 2024
Table 67. Myriad Genetics Revenue Proportion by Geographic Area in 2024
Table 68. Myriad Genetics Pre-Pregnancy Genetic Screening Service SWOT Analysis
Table 69. Myriad Genetics Recent Developments
Table 70. Quest Diagnostics Corporation Information
Table 71. Quest Diagnostics Description and Major Businesses
Table 72. Quest Diagnostics Product Features and Attributes
Table 73. Quest Diagnostics Revenue (US$ Million) and Gross Margin (2020-2025)
Table 74. Quest Diagnostics Revenue Proportion by Product in 2024
Table 75. Quest Diagnostics Revenue Proportion by Application in 2024
Table 76. Quest Diagnostics Revenue Proportion by Geographic Area in 2024
Table 77. Quest Diagnostics Pre-Pregnancy Genetic Screening Service SWOT Analysis
Table 78. Quest Diagnostics Recent Developments
Table 79. LabCorp Corporation Information
Table 80. LabCorp Description and Major Businesses
Table 81. LabCorp Product Features and Attributes
Table 82. LabCorp Revenue (US$ Million) and Gross Margin (2020-2025)
Table 83. LabCorp Recent Developments
Table 84. GeneDx Corporation Information
Table 85. GeneDx Description and Major Businesses
Table 86. GeneDx Product Features and Attributes
Table 87. GeneDx Revenue (US$ Million) and Gross Margin (2020-2025)
Table 88. GeneDx Recent Developments
Table 89. Vitrolife Corporation Information
Table 90. Vitrolife Description and Major Businesses
Table 91. Vitrolife Product Features and Attributes
Table 92. Vitrolife Revenue (US$ Million) and Gross Margin (2020-2025)
Table 93. Vitrolife Recent Developments
Table 94. Illumina Corporation Information
Table 95. Illumina Description and Major Businesses
Table 96. Illumina Product Features and Attributes
Table 97. Illumina Revenue (US$ Million) and Gross Margin (2020-2025)
Table 98. Illumina Recent Developments
Table 99. BillionToOne Corporation Information
Table 100. BillionToOne Description and Major Businesses
Table 101. BillionToOne Product Features and Attributes
Table 102. BillionToOne Revenue (US$ Million) and Gross Margin (2020-2025)
Table 103. BillionToOne Recent Developments
Table 104. Juno Genetics Corporation Information
Table 105. Juno Genetics Description and Major Businesses
Table 106. Juno Genetics Product Features and Attributes
Table 107. Juno Genetics Revenue (US$ Million) and Gross Margin (2020-2025)
Table 108. Juno Genetics Recent Developments
Table 109. MedGenome Corporation Information
Table 110. MedGenome Description and Major Businesses
Table 111. MedGenome Product Features and Attributes
Table 112. MedGenome Revenue (US$ Million) and Gross Margin (2020-2025)
Table 113. MedGenome Recent Developments
Table 114. 23andMe Corporation Information
Table 115. 23andMe Description and Major Businesses
Table 116. 23andMe Product Features and Attributes
Table 117. 23andMe Revenue (US$ Million) and Gross Margin (2020-2025)
Table 118. 23andMe Recent Developments
Table 119. Sonic Genetics Corporation Information
Table 120. Sonic Genetics Description and Major Businesses
Table 121. Sonic Genetics Product Features and Attributes
Table 122. Sonic Genetics Revenue (US$ Million) and Gross Margin (2020-2025)
Table 123. Sonic Genetics Recent Developments
Table 124. CEN4GEN Corporation Information
Table 125. CEN4GEN Description and Major Businesses
Table 126. CEN4GEN Product Features and Attributes
Table 127. CEN4GEN Revenue (US$ Million) and Gross Margin (2020-2025)
Table 128. CEN4GEN Recent Developments
Table 129. BGI Genomics Corporation Information
Table 130. BGI Genomics Description and Major Businesses
Table 131. BGI Genomics Product Features and Attributes
Table 132. BGI Genomics Revenue (US$ Million) and Gross Margin (2020-2025)
Table 133. BGI Genomics Recent Developments
Table 134. Berry Genomics Corporation Information
Table 135. Berry Genomics Description and Major Businesses
Table 136. Berry Genomics Product Features and Attributes
Table 137. Berry Genomics Revenue (US$ Million) and Gross Margin (2020-2025)
Table 138. Berry Genomics Recent Developments
Table 139. Anoroad Corporation Information
Table 140. Anoroad Description and Major Businesses
Table 141. Anoroad Product Features and Attributes
Table 142. Anoroad Revenue (US$ Million) and Gross Margin (2020-2025)
Table 143. Anoroad Recent Developments
Table 144. KingMed Diagnostics Corporation Information
Table 145. KingMed Diagnostics Description and Major Businesses
Table 146. KingMed Diagnostics Product Features and Attributes
Table 147. KingMed Diagnostics Revenue (US$ Million) and Gross Margin (2020-2025)
Table 148. KingMed Diagnostics Recent Developments
Table 149. CapitalBio Technology Corporation Information
Table 150. CapitalBio Technology Description and Major Businesses
Table 151. CapitalBio Technology Product Features and Attributes
Table 152. CapitalBio Technology Revenue (US$ Million) and Gross Margin (2020-2025)
Table 153. CapitalBio Technology Recent Developments
Table 154. Raw Materials Key Suppliers
Table 155. Distributors List
Table 156. Market Trends and Market Evolution
Table 157. Market Drivers and Opportunities
Table 158. Market Challenges, Risks, and Restraints
Table 159. Research Programs/Design for This Report
Table 160. Key Data Information from Secondary Sources
Table 161. Key Data Information from Primary Sources
List of Figures
Figure 1. Pre-Pregnancy Genetic Screening Service Product Picture
Figure 2. Global Pre-Pregnancy Genetic Screening Service Market Size Growth Rate by Type, 2020 VS 2024 VS 2031 (US$ Million)
Figure 3. Single Disease Screening Product Picture
Figure 4. Whole Genome Screening Product Picture
Figure 5. Global Pre-Pregnancy Genetic Screening Service Market Size Growth Rate by Application, 2020 VS 2024 VS 2031 (US$ Million)
Figure 6. Medical and Health Institutions
Figure 7. Research and Educational Institutions
Figure 8. Others
Figure 9. Pre-Pregnancy Genetic Screening Service Report Years Considered
Figure 10. Global Pre-Pregnancy Genetic Screening Service Revenue, (US$ Million), 2020 VS 2024 VS 2031
Figure 11. Global Pre-Pregnancy Genetic Screening Service Revenue (2020-2031) & (US$ Million)
Figure 12. Global Pre-Pregnancy Genetic Screening Service Revenue (CAGR) by Region: 2020 VS 2024 VS 2031 (US$ Million)
Figure 13. Global Pre-Pregnancy Genetic Screening Service Revenue Market Share by Region (2020-2031)
Figure 14. Global Pre-Pregnancy Genetic Screening Service Revenue Market Share Ranking (2024)
Figure 15. Tier Distribution by Revenue Contribution (2020 VS 2024)
Figure 16. Single Disease Screening Revenue Market Share by Player in 2024
Figure 17. Whole Genome Screening Revenue Market Share by Player in 2024
Figure 18. Global Pre-Pregnancy Genetic Screening Service Revenue Market Share by Type (2020-2031)
Figure 19. Global Pre-Pregnancy Genetic Screening Service Revenue Market Share by Application (2020-2031)
Figure 20. North America Pre-Pregnancy Genetic Screening Service Revenue YoY (2020-2031) & (US$ Million)
Figure 21. North America Top 5 Players Pre-Pregnancy Genetic Screening Service Revenue (US$ Million) in 2024
Figure 22. North America Pre-Pregnancy Genetic Screening Service Revenue (US$ Million) by Type (2020 - 2031)
Figure 23. North America Pre-Pregnancy Genetic Screening Service Revenue (US$ Million) by Application (2020-2031)
Figure 24. US Pre-Pregnancy Genetic Screening Service Revenue (2020-2031) & (US$ Million)
Figure 25. Canada Pre-Pregnancy Genetic Screening Service Revenue (2020-2031) & (US$ Million)
Figure 26. Mexico Pre-Pregnancy Genetic Screening Service Revenue (2020-2031) & (US$ Million)
Figure 27. Europe Pre-Pregnancy Genetic Screening Service Revenue YoY (2020-2031) & (US$ Million)
Figure 28. Europe Top 5 Players Pre-Pregnancy Genetic Screening Service Revenue (US$ Million) in 2024
Figure 29. Europe Pre-Pregnancy Genetic Screening Service Revenue (US$ Million) by Type (2020-2031)
Figure 30. Europe Pre-Pregnancy Genetic Screening Service Revenue (US$ Million) by Application (2020-2031)
Figure 31. Germany Pre-Pregnancy Genetic Screening Service Revenue (2020-2031) & (US$ Million)
Figure 32. France Pre-Pregnancy Genetic Screening Service Revenue (2020-2031) & (US$ Million)
Figure 33. U.K. Pre-Pregnancy Genetic Screening Service Revenue (2020-2031) & (US$ Million)
Figure 34. Italy Pre-Pregnancy Genetic Screening Service Revenue (2020-2031) & (US$ Million)
Figure 35. Russia Pre-Pregnancy Genetic Screening Service Revenue (2020-2031) & (US$ Million)
Figure 36. Asia-Pacific Pre-Pregnancy Genetic Screening Service Revenue YoY (2020-2031) & (US$ Million)
Figure 37. Asia-Pacific Top 8 Players Pre-Pregnancy Genetic Screening Service Revenue (US$ Million) in 2024
Figure 38. Asia-Pacific Pre-Pregnancy Genetic Screening Service Revenue (US$ Million) by Type (2020-2031)
Figure 39. Asia-Pacific Pre-Pregnancy Genetic Screening Service Revenue (US$ Million) by Application (2020-2031)
Figure 40. Indonesia Pre-Pregnancy Genetic Screening Service Revenue (2020-2031) & (US$ Million)
Figure 41. Japan Pre-Pregnancy Genetic Screening Service Revenue (2020-2031) & (US$ Million)
Figure 42. South Korea Pre-Pregnancy Genetic Screening Service Revenue (2020-2031) & (US$ Million)
Figure 43. Australia Pre-Pregnancy Genetic Screening Service Revenue (2020-2031) & (US$ Million)
Figure 44. India Pre-Pregnancy Genetic Screening Service Revenue (2020-2031) & (US$ Million)
Figure 45. Indonesia Pre-Pregnancy Genetic Screening Service Revenue (2020-2031) & (US$ Million)
Figure 46. Vietnam Pre-Pregnancy Genetic Screening Service Revenue (2020-2031) & (US$ Million)
Figure 47. Malaysia Pre-Pregnancy Genetic Screening Service Revenue (2020-2031) & (US$ Million)
Figure 48. Philippines Pre-Pregnancy Genetic Screening Service Revenue (2020-2031) & (US$ Million)
Figure 49. Singapore Pre-Pregnancy Genetic Screening Service Revenue (2020-2031) & (US$ Million)
Figure 50. Central and South America Pre-Pregnancy Genetic Screening Service Revenue YoY (2020-2031) & (US$ Million)
Figure 51. Central and South America Top 5 Players Pre-Pregnancy Genetic Screening Service Revenue (US$ Million) in 2024
Figure 52. Central and South America Pre-Pregnancy Genetic Screening Service Revenue (US$ Million) by Type (2020-2031)
Figure 53. Central and South America Pre-Pregnancy Genetic Screening Service Revenue (US$ Million) by Application (2020-2031)
Figure 54. Brazil Pre-Pregnancy Genetic Screening Service Revenue (2020-2025) & (US$ Million)
Figure 55. Argentina Pre-Pregnancy Genetic Screening Service Revenue (2020-2025) & (US$ Million)
Figure 56. Middle East and Africa Pre-Pregnancy Genetic Screening Service Revenue YoY (2020-2031) & (US$ Million)
Figure 57. Middle East and Africa Top 5 Players Pre-Pregnancy Genetic Screening Service Revenue (US$ Million) in 2024
Figure 58. South America Pre-Pregnancy Genetic Screening Service Revenue (US$ Million) by Type (2020-2031)
Figure 59. Middle East and Africa Pre-Pregnancy Genetic Screening Service Revenue (US$ Million) by Application (2020-2031)
Figure 60. GCC Countries Pre-Pregnancy Genetic Screening Service Revenue (2020-2025) & (US$ Million)
Figure 61. Israel Pre-Pregnancy Genetic Screening Service Revenue (2020-2025) & (US$ Million)
Figure 62. Egypt Pre-Pregnancy Genetic Screening Service Revenue (2020-2025) & (US$ Million)
Figure 63. South Africa Pre-Pregnancy Genetic Screening Service Revenue (2020-2025) & (US$ Million)
Figure 64. Pre-Pregnancy Genetic Screening Service Industry Chain Mapping
Figure 65. Channels of Distribution (Direct Vs Distribution)
Figure 66. Bottom-up and Top-down Approaches for This Report
Figure 67. Data Triangulation
Figure 68. Key Executives Interviewed
KEY QUESTIONS ADDRESSED BY THE REPORT
Which companies rank high in the global Pre-Pregnancy Genetic Screening Service market?
The top companies in the global Pre-Pregnancy Genetic Screening Service market are Invitae、Natera、Fulgent Genetics.
What is the annual compound growth rate of the global Pre-Pregnancy Genetic Screening Service market size from 2025 to 2031?
What was the global market size of Pre-Pregnancy Genetic Screening Service in 2025?
Which region is expected to have the highest market share?
What was the global market size of Pre-Pregnancy Genetic Screening Service in 2031?
Related Reports
Global Pre-Pregnancy Genetic Screening Service Market Outlook, In‑Depth Analysis & Forecast to 2032
The global Pre-Pregnancy Genetic Screening Service market is projected to grow from US$ 206 million in 2025 to US$ 378 million by 2032, at a CAGR of 9.2% (2026-2032), driven by critical product segments and diverse end‑use applications.
Published Date: 2026-03-12
Pages: 150
USD 4900.00
(Single User License)
Global Pre-Pregnancy Genetic Screening Service Sales Market Report, Competitive Analysis and Regional Opportunities 2026-2032
The global Pre-Pregnancy Genetic Screening Service market size was US$ 206 million in 2025 and is forecast to reach a readjusted size of US$ 378 million by 2032 with a CAGR of 9.2% during the forecast period 2026-2032.
Published Date: 2026-03-12
Pages: 102
USD 4250.00
(Single User License)
Global Pre-Pregnancy Genetic Screening Service Market Research Report 2026
The global Pre-Pregnancy Genetic Screening Service market was valued at US$ 206 million in 2025 and is anticipated to reach US$ 378 million by 2032, at a CAGR of 9.2% from 2026 to 2032.
Published Date: 2026-03-12
Pages: 128
USD 2900.00
(Single User License)
Pre-Pregnancy Genetic Screening Service - Global Market Share and Ranking, Overall Sales and Demand Forecast 2026-2032
The global market for Pre-Pregnancy Genetic Screening Service was estimated to be worth US$ 206 million in 2025 and is projected to reach US$ 378 million, growing at a CAGR of 9.2% from 2026 to 2032.
Published Date: 2026-03-09
Pages: 132
USD 3950.00
(Single User License)
Pre-Pregnancy Genetic Screening Service - Global Market Share and Ranking, Overall Sales and Demand Forecast 2025-2031
The global market for Pre-Pregnancy Genetic Screening Service was estimated to be worth US$ 189 million in 2024 and is forecast to a readjusted size of US$ 349 million by 2031 with a CAGR of 9.2% during the forecast period 2025-2031.
Published Date: 2025-08-22
Pages: 126
USD 3950.00
(Single User License)
Global Pre-Pregnancy Genetic Screening Service Market Research Report 2025
The global market for Pre-Pregnancy Genetic Screening Service was valued at US$ 189 million in the year 2024 and is projected to reach a revised size of US$ 349 million by 2031, growing at a CAGR of 9.2% during the forecast period.
Published Date: 2025-08-22
Pages: 95
USD 2900.00
(Single User License)
Global Pre-Pregnancy Genetic Screening Service Sales Market Report, Competitive Analysis and Regional Opportunities 2025-2031
The global Pre-Pregnancy Genetic Screening Service market size was US$ 189 million in 2024 and is forecast to a readjusted size of US$ 349 million by 2031 with a CAGR of 9.2% during the forecast period 2025-2031.
Published Date: 2025-08-22
Pages: 103
USD 4250.00
(Single User License)
Global Pre-Pregnancy Genetic Screening Service Market Outlook, In‑Depth Analysis & Forecast to 2032
The global Pre-Pregnancy Genetic Screening Service market is projected to grow from US$ 206 million in 2025 to US$ 378 million by 2032, at a CAGR of 9.2% (2026-2032), driven by critical product segments and diverse end‑use applications.
Published: 2026-03-12
Pages: 150
USD 4900.00 (Single User License)Global Pre-Pregnancy Genetic Screening Service Sales Market Report, Competitive Analysis and Regional Opportunities 2026-2032
The global Pre-Pregnancy Genetic Screening Service market size was US$ 206 million in 2025 and is forecast to reach a readjusted size of US$ 378 million by 2032 with a CAGR of 9.2% during the forecast period 2026-2032.
Published: 2026-03-12
Pages: 102
USD 4250.00 (Single User License)Global Pre-Pregnancy Genetic Screening Service Market Research Report 2026
The global Pre-Pregnancy Genetic Screening Service market was valued at US$ 206 million in 2025 and is anticipated to reach US$ 378 million by 2032, at a CAGR of 9.2% from 2026 to 2032.
Published: 2026-03-12
Pages: 128
USD 2900.00 (Single User License)Pre-Pregnancy Genetic Screening Service - Global Market Share and Ranking, Overall Sales and Demand Forecast 2026-2032
The global market for Pre-Pregnancy Genetic Screening Service was estimated to be worth US$ 206 million in 2025 and is projected to reach US$ 378 million, growing at a CAGR of 9.2% from 2026 to 2032.
Published: 2026-03-09
Pages: 132
USD 3950.00 (Single User License)Pre-Pregnancy Genetic Screening Service - Global Market Share and Ranking, Overall Sales and Demand Forecast 2025-2031
The global market for Pre-Pregnancy Genetic Screening Service was estimated to be worth US$ 189 million in 2024 and is forecast to a readjusted size of US$ 349 million by 2031 with a CAGR of 9.2% during the forecast period 2025-2031.
Published: 2025-08-22
Pages: 126
USD 3950.00 (Single User License)Global Pre-Pregnancy Genetic Screening Service Market Research Report 2025
The global market for Pre-Pregnancy Genetic Screening Service was valued at US$ 189 million in the year 2024 and is projected to reach a revised size of US$ 349 million by 2031, growing at a CAGR of 9.2% during the forecast period.
Published: 2025-08-22
Pages: 95
USD 2900.00 (Single User License)Global Pre-Pregnancy Genetic Screening Service Sales Market Report, Competitive Analysis and Regional Opportunities 2025-2031
The global Pre-Pregnancy Genetic Screening Service market size was US$ 189 million in 2024 and is forecast to a readjusted size of US$ 349 million by 2031 with a CAGR of 9.2% during the forecast period 2025-2031.
Published: 2025-08-22
Pages: 103
USD 4250.00 (Single User License)
CHOOSE LICENSE TYPE
USD 4900.00
USD 7350.00
USD 9800.00
Add to Cart
Buy Now
HAVE A QUESTION?
General Email:
REPORT COVERAGE
DESCRIPTION
OVERVIEW
MARKET SEGMENTATION
CHAPTER OUTLINE
WHY THIS REPORT
QYRESEARCH'S STRENGTHS
TABLE OF CONTENTS
TABLE OF FIGURES
RLEATED REPORTS
INTEREST IN THIS REPORT?
Get A Free Sample
Request For Quotation
OR
NEED A CUSTOMIZED REPORT?
Customized Report
Request Sample
Pre-Order Enquiry
Add to Cart
Buy Now